Items where authors include "Palleis, C."

Article

Dilcher, R. orcid.org/0000-0002-1307-6747, Wall, S., Groß, M. et al. (27 more authors) (2024) Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies. Alzheimer's & Dementia, 20 (10). pp. 6896-6909. ISSN 1552-5260

Malpetti, M. orcid.org/0000-0001-8923-9656, Roemer, S.N., Harris, S. et al. (20 more authors) (2024) Neuroinflammation parallels 18F‐PI‐2620 positron emission tomography patterns in primary 4‐repeat tauopathies. Movement Disorders, 39 (9). pp. 1480-1492. ISSN 0885-3185

Stockbauer, A., Beyer, L., Huber, M. et al. (39 more authors) (2024) Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. European Journal of Nuclear Medicine and Molecular Imaging, 51. pp. 1023-1034. ISSN 1619-7070

Biechele, G., Rauchmann, B.-S., Janowitz, D. et al. (30 more authors) (2024) Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease. Journal of Neuroinflammation, 21 (1). 30. ISSN 1742-2094

Finze, A., Biechele, G., Rauchmann, B.-S. et al. (41 more authors) (2023) Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Molecular Psychiatry, 28 (10). pp. 4438-4450. ISSN 1359-4184

Völter, F., Beyer, L., Eckenweber, F. et al. (17 more authors) (2023) Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings. European Journal of Nuclear Medicine and Molecular Imaging, 50 (5). pp. 1384-1394. ISSN 1619-7070

Schuster, S., Beyer, L. orcid.org/0000-0002-7358-4495, Palleis, C. et al. (21 more authors) (2022) Impact of partial volume correction on [18F]GE-180 PET quantification in subcortical brain regions of patients with corticobasal syndrome. Brain Sciences, 12 (2). 204. ISSN 2076-3425